Novel risk factors for venous thromboembolism

Hematol Oncol Clin North Am. 2010 Aug;24(4):709-16, viii. doi: 10.1016/j.hoc.2010.05.007.

Abstract

VTE can be considered as a multicausal disease involving various inherited and acquired prothrombotic conditions. Although greater emphasis has classically been given to traditional thrombophilic risk factors, there is increasing recognition of less typical precipitating conditions and events. In this article, the authors focus on the most promising, persistent, and potentially treatable novel risk factors.

MeSH terms

  • Cardiovascular Diseases / complications
  • Clinical Trials as Topic
  • Endocrine System Diseases / complications
  • Humans
  • Janus Kinase 2 / genetics
  • Mutation / genetics
  • Myeloproliferative Disorders / complications
  • Risk Factors
  • Venous Thromboembolism / etiology*
  • Venous Thromboembolism / pathology

Substances

  • JAK2 protein, human
  • Janus Kinase 2